ITRM vs MKTX · rev $390.0K vs P/E 13, rev $817.1M
Iterum Therapeutics PLC (ITRM) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
ITRM currently screens at market cap $38.6M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the ITRM and MKTX stock pages for the full models.
Not investment advice.